The therapeutic role of orofacial myofunctional therapy in childhood obstructive sleep apnea

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072252

Enrollment

Unknown

Registered

2023-06-07

Start date

2023-06-30

Completion date

Unknown

Last updated

2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood obstructive sleep apnea

Interventions

intervention group:Receiving OMT treatment

Eligibility

Sex/Gender

All

Age

4 Years to 11 Years

Inclusion criteria

Inclusion criteria: (1) between 4 and 11 years of age (2) Apnea hypopnea index (AHI) above 1

Exclusion criteria

Exclusion criteria: (1) children who refused to cooperate with treatment (2) craniofacial abnormalities, neuromuscular disease and comorbidities such as Down syndrome and Crouzon syndrome

Design outcomes

Primary

Measure	Time frame
Apnea hypopnea index;OMES;	—

Secondary

Measure	Time frame
Oxygen desaturation index;Maximum pause time;Average oxygen saturation during sleep;LSpO2;Modified OSA-18 questionnaires;the degree of mouth opening;	—

Countries

China

Contacts

Public ContactWang Tiansheng

Third Xiangya Hospital, Central South University

tswheaven@hotmail.com+86 138 7496 4065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026